ask="N/A"
ask_size="N/A"
average_daily_volume="371710"
bid="31.11"
bid_size="100"
book_value="6.19"
change="-0.09"
change_from_200_day_moving_average="1.02"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-7.68"
change_From_52_week_low="17.65"
change_in_percent="-0.29%"
close="31.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="31.65"
high_52_weeks="38.92"
last_trade_date="2/6/2017"
last_trade_price="31.24"
last_trade_size="8277"
last_trade_time="4:00pm"
low="30.80"
low_52_weeks="13.59"
market_capitalization="1.62B"
moving_average_200_day="30.22"
moving_average_50_day="31.43"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="31.28"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+3.38%"
percent_change_from_50_day_moving_average="-0.61%"
percent_change_from_52_week_high="-19.73%"
percent_change_from_52_week_low="+129.87%"
previous_close="31.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.06"
price_per_sales="34.74"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="18.07"
stock_exchange="NGM"
symbol="TBPH"
volume="145501"
weeks_range_52="13.59 - 38.92"
